Detection and Drug-resistance Analysis of Extended Spectum ?-Lactamases Producing Escherichia coli and Klebsiella pneumoniae / 中华医院感染学杂志
Chinese Journal of Nosocomiology
;
(24)2006.
Article
Dans Chinois
| WPRIM
| ID: wpr-594497
ABSTRACT
OBJECTIVE To investigate drug resistance characteristice of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum?-lactamases(ESBLs) in our hospital so as to instruct rational use of antibiotics in clinic. METHODS The ESBLs were determined by the sensitivity and confirming tests according to NCCLS(1999) standard. RESULTS The isolated ratio of ESBLs producing E. coli and K. pneumoniae increased from 28.6% and 29.2% in 2005 to 48.5% and 49.2% in 2007. Extended-Spectum ?-Lactamases germs showed high resistance to cephalosporins-1G, 2G, 3G, to Penicillin and to Am Aztreonam. The rate of sensitivity to imipenem was 100.0%. CONCLUSIONS There is an increasing trend of ESBLs producing E. coli and K. pneumoniae. The imipenem is the best drug for treatment the bacterium producing ESBLs.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Type d'étude:
Etude diagnostique
langue:
Chinois
Texte intégral:
Chinese Journal of Nosocomiology
Année:
2006
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS